Editorial
Clinical Trial Registration: A Statement from the International Committee of Medical Journal Editors
N Engl J Med 2004; 351:1250-1251September 16, 2004
- Article
Altruism and trust lie at the heart of research on human subjects. Altruistic individuals volunteer for research because they trust that their participation will contribute to improved health for others and that researchers will minimize risks to participants. In return for the altruism and trust that make clinical research possible, the research enterprise has an obligation to conduct research ethically and to report it honestly. Honest reporting begins with revealing the existence of all clinical studies, even those that reflect unfavorably on a research sponsor's product.
Unfortunately, selective reporting of trials does occur, and it distorts the body of evidence available for clinical decision-making. Researchers (and journal editors) are generally most enthusiastic about the publication of trials that show either a large effect of a new treatment (positive trials) or equivalence of two approaches to treatment (non-inferiority trials). Researchers (and journals) typically are less excited about trials that show that a new treatment is inferior to standard treatment (negative trials) and even less interested in trials that are neither clearly positive nor clearly negative, since inconclusive trials will not in themselves change practice. Irrespective of their scientific interest, trial results that place financial interests at risk are particularly likely to remain unpublished and hidden from public view. The interests of the sponsor or authors notwithstanding, anyone should be able to learn of any trial's existence and its important characteristics.
The case against selective reporting is particularly compelling for research that tests interventions that could enter mainstream clinical practice. Rather than a single trial, it is usually a body of evidence, consisting of many studies, that changes medical practice. When research sponsors or investigators conceal the presence of selected trials, these studies cannot influence the thinking of patients, clinicians, other researchers, and experts who write practice guidelines or decide on insurance-coverage policy. If all trials are registered in a public repository at their inception, every trial's existence is part of the public record and the many stakeholders in clinical research can explore the full range of clinical evidence. We are far from this ideal at present, since trial registration is largely voluntary, registry data sets and public access to them varies, and registries contain only a small proportion of trials. In this editorial, published simultaneously in all member journals, the International Committee of Medical Journal Editors (ICMJE) proposes comprehensive trials registration as a solution to the problem of selective awareness and announces that all eleven ICMJE member journals will adopt a trials-registration policy to promote this goal.
The ICMJE member journals will require, as a condition of consideration for publication, registration in a public trials registry. Trials must register at or before the onset of patient enrollment. This policy applies to any clinical trial starting enrollment after July 1, 2005. For trials that began enrollment before this date, the ICMJE member journals will require registration by September 13, 2005, before considering the trial for publication. We speak only for ourselves, but we encourage editors of other biomedical journals to adopt similar policies. For this purpose, the ICMJE defines a clinical trial as any research project that prospectively assigns human subjects to intervention or comparison groups to study the cause-and-effect relationship between a medical intervention and a health outcome. Studies designed for other purposes, such as to study pharmacokinetics or major toxicity (e.g., phase 1 trials), would be exempt.
The ICMJE does not advocate one particular registry, but its member journals will require authors to register their trial in a registry that meets several criteria. The registry must be accessible to the public at no charge. It must be open to all prospective registrants and managed by a not-for-profit organization. There must be a mechanism to ensure the validity of the registration data, and the registry should be electronically searchable. An acceptable registry must include at minimum the following information: a unique identifying number, a statement of the intervention (or interventions) and comparison (or comparisons) studied, a statement of the study hypothesis, definitions of the primary and secondary outcome measures, eligibility criteria, key trial dates (registration date, anticipated or actual start date, anticipated or actual date of last follow-up, planned or actual date of closure to data entry, and date trial data considered complete), target number of subjects, funding source, and contact information for the principal investigator. To our knowledge, at present, only www.clinicaltrials.gov, sponsored by the United States National Library of Medicine, meets these requirements; there may be other registries, now or in the future, that meet all these requirements.
Registration is only part of the means to an end; that end is full transparency with respect to performance and reporting of clinical trials. Research sponsors may argue that public registration of clinical trials will result in unnecessary bureaucratic delays and destroy their competitive edge by allowing competitors full access to their research plans. We argue that enhanced public confidence in the research enterprise will compensate for the costs of full disclosure. Patients who volunteer to participate in clinical trials deserve to know that their contribution to improving human health will be available to inform health care decisions. The knowledge made possible by their collective altruism must be accessible to everyone. Required trial registration will advance this goal.
Source Information
Editor-in-Chief, JAMA
Editor-in-Chief, New England Journal of Medicine
Editor, The New Zealand Medical Journal
Editor-in-Chief, Norwegian Medical Journal
Editor, CMAJ
Editor, The Lancet
Executive Editor, MEDLINE, National Library of Medicine
Senior Deputy Editor, Annals of Internal Medicine
Editor, Croatian Medical Journal
Executive Editor, Nederlands Tijdschrift voor Geneeskunde, (Dutch Journal of Medicine)
Editor, Journal of the Danish Medical Association
Editor, Annals of Internal Medicine
Editor, The Medical Journal of Australia
- Citing Articles (124)
Citing Articles
1
Yan Wang, Cheng-long Xie, Deng-lei Fu, Lin Lu, Yan Lin, Qi-qian Dong, Xiao-tong Wang, Guo-qing Zheng. (2012) Clinical efficacy and safety of Chinese herbal medicine for Wilson's disease: A systematic review of 9 randomized controlled trials. Complementary Therapies in Medicine 20:3, 143-154
CrossRef2
Christopher W. Jones, Timothy F. Platts-Mills. (2012) Quality of Registration for Clinical Trials Published in Emergency Medicine Journals. Annals of Emergency Medicine
CrossRef3
Timothy L. Lash, Jan P. Vandenbroucke. (2012) Should Preregistration of Epidemiologic Study Protocols Become Compulsory?. Epidemiology 23:2, 184-188
CrossRef4
Jared T. Wilcox, David Cadotte, Michael G. Fehlings. (2012) Spinal Cord Clinical Trials and the Role for Bioengineering. Neuroscience Letters
CrossRef5
2012. Trial Reporting. , 218-265.
CrossRef6
M.N. Hurley, A.P. Prayle, A.R. Smyth. (2012) Delayed publication of clinical trials in cystic fibrosis. Journal of Cystic Fibrosis 11:1, 14-17
CrossRef7
Elliott M. Antman. 2012. Design and Conduct of Clinical Trials. , 49-55.
CrossRef8
Taixiang Wu, Youping Li, Shangwei Zhen, Shaolin Deng, Linzhi Zhang, Chenfang Fan, Wannan Jia, Zihong Zhong, Liang Du, Xuemei Liu, Qinghui Zhou, Yanli Xu, Keji Chen, Zhaoxiang Bian, Vivian Wong, . (2011) Joint statement on promoting development of publication ethics among medical journals in China. Journal of Evidence-Based Medicineno-no
CrossRef9
Jonathan L Marks, Alexandra N Colebatch, Rachelle Buchbinder, Christopher J Edwards, Jonathan L Marks. 2011. Pain management for rheumatoid arthritis and cardiovascular or renal comorbidity. .
CrossRef10
Masoud Solaymani-Dodaran, Davood Khalili, Hamed Hosseini, Laily Najafi, Kourosh Kamali, Parvaneh Ranjbar, Hassan Tavakoli, Afshin Ostovar. (2011) Iranian Registry of Clinical Trials two years on and the timing of registrations. Journal of Evidence-Based Medicine 4:3, 168-171
CrossRef11
Wasee Tulvatana, Kittisak Kulvichit, Bandit Thinkhamrop, Pyatat Tatsanavivat. (2011) Thai Clinical Trials Registry. Journal of Evidence-Based Medicine 4:3, 182-184
CrossRef12
J. M. Smoliga, O. Vang, J. A. Baur. (2011) Challenges of Translating Basic Research Into Therapeutics: Resveratrol as an Example. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences
CrossRef13
Andres De Los Reyes, Shannon M.A. Kundey, Mo Wang. (2011) The end of the primary outcome measure: A research agenda for constructing its replacement. Clinical Psychology Review 31:5, 829-838
CrossRef14
I. Pauporté, E. Manach, N. Bachouche, M. Duperrey, A. Hommais. (2011) Fréquentation du registre français des essais cliniques en cancérologie et information recherchée par les patients et proches. Oncologie 13:6, 305-310
CrossRef15
2011. References. , 193-223.
CrossRef16
Michael B. Bracken. (2011) Preregistration of Epidemiology Protocols. Epidemiology 22:2, 135-137
CrossRef17
Fabrice Andre, Lisa M. McShane, Stefan Michiels, David F. Ransohoff, Douglas G. Altman, Jorge S. Reis-Filho, Daniel F. Hayes, Lajos Pusztai. (2011) Biomarker studies: a call for a comprehensive biomarker study registry. Nature Reviews Clinical Oncology 8:3, 171-176
CrossRef18
Jonathan L Marks, Alexandra N Colebatch, Rachelle Buchbinder, Christopher J Edwards, Jonathan L Marks. 2011. Pain management for rheumatoid arthritis and cardiovascular or renal co-morbidity. .
CrossRef19
Sun-Wei Guo, Maohua Liu, Fanghua Shen, Xishi Liu. (2011) Use of mifepristone to treat endometriosis: a review of clinical trials and trial-like studies conducted in China. Women's Health 7:1, 51-70
CrossRef20
Alessandra N Garcia, Francine LB Gondo, Renata A Costa, Fábio N Cyrillo, Tatiane M Silva, Luciola CM Costa, Leonardo OP Costa. (2011) Effectiveness of the back school and mckenzie techniques in patients with chronic non-specific low back pain: a protocol of a randomised controlled trial. BMC Musculoskeletal Disorders 12:1, 179
CrossRef21
Hiroshi Sawata, Kiichiro Tsutani. (2011) How Can the Evidence from Global Large-scale Clinical Trials for Cardiovascular Diseases be Improved?. BMC Research Notes 4:1, 222
CrossRef22
Hiroshi Sawata, Kiichiro Tsutani. (2011) Funding and infrastructure among large-scale clinical trials examining cardiovascular diseases in Japan: evidence from a questionnaire survey. BMC Medical Research Methodology 11:1, 148
CrossRef23
Shiro Tanaka. (2011) Ethical Issues in Clinical and Epidemiological Studies of Nutrition and Food Science. Nippon Eiyo Shokuryo Gakkaishi 64:5, 291-295
CrossRef24
R. E. Becker, N. H. Greig. (2010) Lost in Translation: Neuropsychiatric Drug Development. Science Translational Medicine 2:61, 61rv6-61rv6
CrossRef25
Anthony W. Fox. 2010. Publishing Clinical Studies. , 608-615.
CrossRef26
L. Reveiz, M. Cortés-Jofré, C. Asenjo Lobos, G. Nicita, A. Ciapponi, M. Garcìa-Dieguez, D. Tellez, M. Delgado, I. Solà, E. Ospina. (2010) Influence of trial registration on reporting quality of randomized trials: Study from highest ranked journals. Journal of Clinical Epidemiology 63:11, 1216-1222
CrossRef27
2010. References. , 165-193.
CrossRef28
William Tarnow-Mordi, David Isaacs, Sourabh Dutta. (2010) Adjunctive Immunologic Interventions in Neonatal Sepsis. Clinics in Perinatology 37:2, 481-499
CrossRef29
Dan Kottachchi, Geoffrey C. Nguyen. (2010) Quality and publication success of abstracts of randomized clinical trials in inflammatory bowel disease presented at Digestive Disease Week. Inflammatory Bowel Diseases 16:6, 993-998
CrossRef30
B. Seruga, P. C. Hertz, L. W. Le, I. F. Tannock. (2010) Global drug development in cancer: a cross-sectional study of clinical trial registries. Annals of Oncology 21:4, 895-900
CrossRef31
F. Alfonso, G. Ambrosio, F. J. Pinto, H. Ector, P. Vardas, P. Kulakowski, A. Timmis, . (2010) European Society of Cardiology National Cardiovascular Journals: the 'Editors' Network'. European Heart Journal 31:1, 26-28
CrossRef32
Lorenzo Moja. (2010) Clinical trials: Trial registration cannot alone transform scientific conduct. Nature Reviews Urology 7:1, 7-8
CrossRef33
Ana Marusic. (2009) Can Journal Editors Police Animal Welfare? Three Es for Three Rs in Scientific Journals. The American Journal of Bioethics 9:12, 66-67
CrossRef34
(2009) The evolution of trial registration. Nature Reviews Drug Discovery 8:10, 755-755
CrossRef35
Gary D. Novack. (2009) Clinical Trial Registry—Update. The Ocular Surface 7:4, 212-214
CrossRef36
C. Pandolfini, M. Bonati. (2009) Children’s presence in research. A review of online registers. European Journal of Clinical Pharmacology 65:9, 873-880
CrossRef37
W. L. Lanier. (2009) Bidirectional Conflicts of Interest Involving Industry and Medical Journals: Who Will Champion Integrity?. Mayo Clinic Proceedings 84:9, 771-775
CrossRef38
S.-W. Guo, L. Hummelshoj, D. L. Olive, S. E. Bulun, T. M. D'Hooghe, J. L.H. Evers. (2009) A call for more transparency of registered clinical trials on endometriosis. Human Reproduction 24:6, 1247-1254
CrossRef39
Thomas J. Liesegang. (2009) Revealing the faults in medical journals. Archivum Immunologiae et Therapiae Experimentalis 57:2, 75-83
CrossRef40
Prathap Tharyan. (2009) Prospective Registration of Clinical Trials in India: Strategies, Achievements & Challenges. Journal of Evidence-Based Medicine 2:1, 19-28
CrossRef41
Hanna Hasselblatt, Gabriele Dreier, Gerd Antes, Martin Schumacher. (2009) The German Clinical Trials Register: challenges and chances of implementing a bilingual registry. Journal of Evidence-Based Medicine 2:1, 36-40
CrossRef42
Masoud Solaymani-Dodaran, Afshin Ostovar, Davood Khalili, Muhammad Vasei. (2009) Iranian Registry of Clinical Trials: path and challenges from conception to a World Health Organization primary register. Journal of Evidence-Based Medicine 2:1, 32-35
CrossRef43
Nigel J Hall, Maurizio Pacilli, Simon Eaton, Kim Reblock, Barbara A Gaines, Aimee Pastor, Jacob C Langer, Antti I Koivusalo, Mikko P Pakarinen, Lutz Stroedter, Stefan Beyerlein, Munther Haddad, Simon Clarke, Henri Ford, Agostino Pierro. (2009) Recovery after open versus laparoscopic pyloromyotomy for pyloric stenosis: a double-blind multicentre randomised controlled trial. The Lancet 373:9661, 390-398
CrossRef44
Edward Abraham. (2009) Better infrastructure: Industry–academia partnerships—A marriage of convenience?. Critical Care Medicine 37:Supplement, S159-S164
CrossRef45
Massimo Antonelli, Giovanna Mercurio. (2009) Reporting, access, and transparency: Better infrastructure of clinical trials. Critical Care Medicine 37:Supplement, S178-S183
CrossRef46
Julia M. Hush, Robert D. Herbert. (2009) Scientific fraud in physiotherapy: prevention is better than cure. Australian Journal of Physiotherapy 55:2, 77-78
CrossRef47
Guido Barbagli, Massimo Lazzeri. (2008) Can Reconstructive Urethral Surgery Proceed Without Randomised Controlled Trials?. European Urology 54:4, 709-711
CrossRef48
Apostolia M. Tsimberidou, Elihu Estey. (2008) Relevance of clinical trials in acute myeloid leukaemia. Hematological Oncology 26:3, 182-183
CrossRef49
Fernando Alfonso, Giuseppe Ambrosio, Fausto J Pinto, Ernst E van der Wall. (2008) European National Society Cardiovascular Journals: Background, Rationale and Mission Statement of the ‘Editorsʼ Club’ (Task Force of the European Society of Cardiology). Journal of Cardiovascular Medicine 9:9, 872-877
CrossRef50
Johan P. E. Karlberg. (2008) Trends in disease focus of drug development. Nature Reviews Drug Discovery 7:8, 639-640
CrossRef51
Fernando Alfonso, Giuseppe Ambrosio, Fausto J. Pinto, Ernst E. Wall. (2008) European National Society Cardiovascular Journals. Clinical Research in Cardiology 97:6, 349-355
CrossRef52
Fernando Alfonso, Giuseppe Ambrosio, Fausto J. Pinto, Ernst E. Van der Wall. (2008) Revistas cardiovasculares de las sociedades nacionales europeas. Antecedentes, fundamento y declaración de objetivos del «Club de Editores». Revista Española de Cardiología 61:6, 644-650
CrossRef53
Chiara Pandolfini, Maurizio Bonati, Valentina Rossi, Eugenio Santoro, Imti Choonara, Coral Naylor, Helen Sammons, Evelyne Jacqz-Aigrain, Setareh Zarrabian, Josep Maria Arnau, Josep Maria Castel, Imma Danés, Inma Fuentes. (2008) The DEC-net European register of paediatric drug therapy trials: contents and context. European Journal of Clinical Pharmacology 64:6, 611-617
CrossRef54
Johan P. E. Karlberg. (2008) Globalization of sponsored clinical trials. Nature Reviews Drug Discovery 7:5, 458-458
CrossRef55
Johan C. F. van Luijn, Pieter Stolk, Frank W. J. Gribnau, Hubert G. M. Leufkens. (2008) Gap in publication of comparative information on new medicines. British Journal of Clinical Pharmacology 65:5, 716-722
CrossRef56
Yoshikazu MIWA. (2008) Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 39:5, 157-161
CrossRef57
Ron A Bouchard, Trudo Lemmens. (2008) Privatizing biomedical research—a 'third way'. Nature Biotechnology 26:1, 31-36
CrossRef58
Joan Rovira. (2008) Transparency of Economic Evaluations of Health Technologies. PharmacoEconomics 26:3, 181-183
CrossRef59
William L. Lanier. (2008) Mayo Clinic Proceedings 2008: Content Refinement, Continuing Medical Education Credit, Web Site Improvements, and More. Mayo Clinic Proceedings 83:1, 13-16
CrossRef60
J. Ermann, B. L. Bermas. (2007) The biology behind the new therapies for SLE. International Journal of Clinical Practice 61:12, 2113-2119
CrossRef61
Leon Flicker, Osvaldo P. Almeida. (2007) Commentary. International Psychogeriatrics 19:06,
CrossRef62
Lisa N. Abaid, David A. Grimes, Kenneth F. Schulz. (2007) Reducing publication bias of prospective clinical trials through trial registration. Contraception 76:5, 339-341
CrossRef63
Drazen, Jeffrey M., Morrissey, Stephen, Curfman, Gregory D., . (2007) Open Clinical Trials. New England Journal of Medicine 357:17, 1756-1757
Full Text64
(2007) Consensus Statement on Mandatory Registration of Clinical Trials. Surgery 141:6, 703-704
CrossRef65
Gunnar Lose. (2007) Urogynaecological research: current and future developments. International Urogynecology Journal 18:6, 599-601
CrossRef66
(2007) Trial Registration. New England Journal of Medicine 356:15, 1581-1581
Full Text67
B. C.K. Choi, J. Frank, J. S. Mindell, A. Orlova, V. Lin, A. D.M.G. Vaillancourt, P. Puska, T. Pang, H. A. Skinner, M. Marsh, A. H. Mokdad, S.-Z. Yu, M. C. Lindner, G. Sherman, S. M. Barreto, L. W. Green, L. W. Svenson, P. Sainsbury, Y. Yan, Z.-F. Zhang, J. C. Zevallos, S. C. Ho, L. M. de Salazar. (2007) Vision for a Global Registry of Anticipated Public Health Studies. American Journal of Public Health 97:Supplement 1, S82-S87
CrossRef68
&NA;. (2007) Consensus Statement on Mandatory Registration of Clinical Trials. Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 17:2, 71-72
CrossRef69
(2007) Consensus statement on mandatory registration of clinical trials. British Journal of Surgery 94:4, 511-512
CrossRef70
(2007) Consensus statement on mandatory registration of clinical trials. Journal of Vascular Surgery 45:4, 845
CrossRef71
(2007) Consensus Statement on Mandatory Registration of Clinical Trials. The Annals of Thoracic Surgery 83:4, 1583-1584
CrossRef72
Marc GH Besselink, Hjalmar C van Santvoort, Ben J Witteman, Hein G Gooszen. (2007) Management of severe acute pancreatitis: itʼs all about timing. Current Opinion in Critical Care 13:2, 200-206
CrossRef73
(2007) Consensus statement on mandatory registration of clinical trials. Journal of Pediatric Surgery 42:4, 601-602
CrossRef74
M. Carolina Hinestrosa, Kay Dickersin, Pamela Klein, Musa Mayer, Karin Noss, Dennis Slamon, George Sledge, Frances M. Visco. (2007) Shaping the future of biomarker research in breast cancer to ensure clinical relevance. Nature Reviews Cancer 7:4, 309-315
CrossRef75
Linda Brubaker. (2007) Clinical trial registration. Neurourology and Urodynamics 26:2, 147-147
CrossRef76
Alan E. Jones. (2007) What Vasopressors Should Be Used to Treat Shock?. Annals of Emergency Medicine 49:3, 367-368
CrossRef77
Harvey Sugerman. (2007) Consensus statement on mandatory registration of clinical trials. Surgery for Obesity and Related Diseases 3:2, 107-108
CrossRef78
Richard O Day, Kenneth M Williams. (2007) Open-Label Extension Studies. Drug Safety 30:2, 93-105
CrossRef79
William R. Hendee. (2007) Research with Human Volunteers. Medical Physics 34:7, 3119
CrossRef80
Jack L. Cronenwett, James M. Seeger. (2007) Requirement for registration of clinical trials. Journal of Vascular Surgery 45:1, 1
CrossRef81
Daniela Seminara, Muin J. Khoury, Thomas R. O??Brien, Teri Manolio, Marta L. Gwinn, Julian Little, Julian P. T. Higgins, Jonine L. Bernstein, Paolo Boffetta, Melissa Bondy, Molly S. Bray, Paul E. Brenchley, Patricia A. Buffler, Juan Pablo Casas, Anand P. Chokkalingam, John Danesh, George Davey Smith, Siobhan Dolan, Ross Duncan, Nelleke A. Gruis, Mia Hashibe, David Hunter, Marjo-Riitta Jarvelin, Beatrice Malmer, Demetrius M. Maraganore, Julia A. Newton-Bishop, Elio Riboli, Georgia Salanti, Emanuela Taioli, Nic Timpson, Andr?? G. Uitterlinden, Paolo Vineis, Nick Wareham, Deborah M. Winn, Ron Zimmern, John P. A. Ioannidis. (2007) The Emergence of Networks in Human Genome Epidemiology. Epidemiology 18:1, 1-8
CrossRef82
Fernando Alfonso, Javier Segovia, Magda Heras, Javier Bermejo. (2006) Publicación de ensayos clínicos en revistas científicas: consideraciones editoriales. Revista Española de Cardiología 59:11, 1206-1214
CrossRef83
Andrew P. Schachat. (2006) Enhancements. Ophthalmology 113:10, 1694
CrossRef84
David B. Resnik. (2006) Openness versus Secrecy in Scientific Research. Episteme 2:03, 135-147
CrossRef85
A. Mazin Safar, Patricia O'Sullivan, Linda Ray, Laura Hutchins, Paulette Mehta. (2006) Editorial Clubs as a New Teaching Tool in Postgraduate Training. Journal of Cancer Education 21:3, 163-165
CrossRef86
Alan Lyles. (2006) The reference case ten years later: Has comparing cost-effectiveness analyses improved?. Clinical Therapeutics 28:8, 1182-1183
CrossRef87
Olga Jonasson. (2006) Reply. Journal of the American College of Surgeons 203:1, 141
CrossRef88
Ludovic Reveiz, Andres Felipe Cardona, Edgar Guillermo Ospina, Sylvia de Agular. (2006) An e-mail survey identified unpublished studies for systematic reviews. Journal of Clinical Epidemiology 59:7, 755-758
CrossRef89
Bonnie W. Ramsey. (2006) Appropriate compensation of pediatric research participants: Thoughts from an Institute of Medicine committee report. The Journal of Pediatrics 149:1, S15-S19
CrossRef90
E. Jan Irvine, William E. Whitehead, William D. Chey, Kei Matsueda, Michael Shaw, Nicholas J. Talley, Sander J.O. Veldhuyzen van Zanten. (2006) Design of Treatment Trials for Functional Gastrointestinal Disorders. Gastroenterology 130:5, 1538-1551
CrossRef91
Rebecca Dresser. (2006) Private-Sector Research Ethics: Marketing or Good Conflicts Management? The 2005 John J. Conley Lecture on Medical Ethics. Theoretical Medicine and Bioethics 27:2, 115-139
CrossRef92
(2006) Clinical Trials Report Card. New England Journal of Medicine 354:13, 1426-1429
Full Text93
Stefan Leucht. (2006) Translating research into clinical practice: critical interpretation of clinical trials in schizophrenia. International Clinical Psychopharmacology 21:Supplement 2, S1-S10
CrossRef94
Anne O. Carter, Glenn H. Griffin, Thomas P. Carter. (2006) A survey identified publication bias in the secondary literature. Journal of Clinical Epidemiology 59:3, 241-245
CrossRef95
Allan L. Naarden, John Cissik. (2006) Informed Consent. The American Journal of Medicine 119:3, 194-197
CrossRef96
David Gurwitz, Jeantine E. Lunshof, Russ B. Altman. (2006) A call for the creation of personalized medicine databases. Nature Reviews Drug Discovery 5:1, 23-26
CrossRef97
Maurizio Bonati, Chiara Pandolfini. (2006) Trial registration, the International Committee of Medical Journal Editors statement and pediatric journals. Pediatric Anesthesia 16:1, 92-92
CrossRef98
Laurent Garderet, Christelle Mazurier, Catherine Pellat-Deceunynck, Abdul Karim, Bruno Baudin, Christian Funck-Brentano, Sandrine Bouchet, Alexandrine Geffroy, Régis Bataille, Norbert-Claude Gorin, Manuel Lopez. (2006) Poor ex vivo induction of T-cell responses to idiotype or tumor cell lysate-pulsed autologous dendritic cells in advanced pre-treated multiple myeloma. Leukemia & Lymphoma 47:7, 1340-1347
CrossRef99
C. Hanning, P. Rentowl. (2006) A response to 'Living with the European Clinical Trials Directive: one year on'. Anaesthesia 61:1, 78-79
CrossRef100
Tsutomu Yamazaki. (2006) Proposed New Score to Rate the Strength of Evidence and Its Application to Large-Scale Clinical Trials of Angiotensin-Receptor Blockers. Circulation Journal 70:9, 1155-1158
CrossRef101
Zarin, Deborah A., Tse, Tony, Ide, Nicholas C., . (2005) Trial Registration at ClinicalTrials.gov between May and October 2005. New England Journal of Medicine 353:26, 2779-2787
Full Text102
Haug, Charlotte, Gøtzsche, Peter C., Schroeder, Torben V., . (2005) Registries and Registration of Clinical Trials. New England Journal of Medicine 353:26, 2811-2812
Full Text103
Drazen, Jeffrey M., Wood, Alastair J.J., . (2005) Trial Registration Report Card. New England Journal of Medicine 353:26, 2809-2811
Full Text104
Jennifer L. Gold, David M. Studdert. (2005) Clinical Trials Registries: A Reform that is Past Due. The Journal of Law, Medicine & Ethics 33:4, 811-820
CrossRef105
Joshua R Klein, Aaron Roodman. (2005) BLIND ANALYSIS IN NUCLEAR AND PARTICLE PHYSICS. Annual Review of Nuclear and Particle Science 55:1, 141-163
CrossRef106
Joan Rovira-Forns, Fernando Antoñanzas-Villar. (2005) Estudios de evaluación económica en salud. Medicina Clínica 125, 61-71
CrossRef107
S BARTELS. (2005) Evidence-Based Geriatric Psychiatry: An Overview. Psychiatric Clinics of North America 28:4, 763-784
CrossRef108
Carlos Campillo. (2005) Por un registro único de los ensayos clínicos. El papel de los CEIC y las revistas médicas. Medicina Clínica 125:15, 599
CrossRef109
Fred G. Barker, Bob S. Carter. (2005) Synthesizing medical evidence: systematic reviews and metaanalyses. Neurosurgical FOCUS 19:4, 1-21
CrossRef110
De Angelis, Catherine D., , Drazen, Jeffrey M., , M.B.,Ch.B., Prof. Frank A. Frizelle,, , Haug, Charlotte, , Hoey, John, , Horton, Richard, , Kotzin, Sheldon, , Laine, Christine, , Marusic, Ana, , Overbeke, A. John P.M., , Schroeder, Torben V., , Sox, Harold C., , Weyden, Martin B. Van Der, . (2005) Is This Clinical Trial Fully Registered? — A Statement from the International Committee of Medical Journal Editors. New England Journal of Medicine 352:23, 2436-2438
Full Text111
Eric Schwam. (2005) Reply. Academic Emergency Medicine 12:6, 573-574
CrossRef112
Alexa Boer Kimball, Martin A. Weinstock. (2005) Mandatory registration of clinical trials: A major step forward for evidence-based medicine. Journal of the American Academy of Dermatology 52:5, 890-892
CrossRef113
Vicente Alfaro. (2005) Registro de los ensayos clínicos previo a su publicación: nuevo requisito del ICMJE. Medicina Clínica 124:16, 638-639
CrossRef114
Philip F. Halloran, Bruce Kaplan. (2005) Evolving Issues in Clinical Research. American Journal of Transplantation 5:4, 637-638
CrossRef115
Lindberg, Donald A.B., Humphreys, Betsy L., . (2005) 2015 — The Future of Medical Libraries. New England Journal of Medicine 352:11, 1067-1070
Full Text116
(2005) Clinical Trial Registration. New England Journal of Medicine 352:2, 198-199
Full Text117
Walter R. Frontera. (2005) Editorial Notes to Begin 2005. American Journal of Physical Medicine & Rehabilitation 84:1, 1-2
CrossRef118
Zhenglun Pan, Thomas A. Trikalinos, Fotini K. Kavvoura, Joseph Lau, John P.A. Ioannidis. (2005) Local Literature Bias in Genetic Epidemiology: An Empirical Evaluation of the Chinese Literature. PLoS Medicine 2:12, e334
CrossRef119
John P. A. Ioannidis. (2005) Why Most Published Research Findings Are False. PLoS Medicine 2:8, e124
CrossRef120
Jin Ling Tang. (2005) Selection Bias in Meta-Analyses of Gene-Disease Associations. PLoS Medicine 2:12, e409
CrossRef121
Trudo Lemmens. (2004) Leopards in the Temple: Restoring Scientific Integrity to the Commercialized Research Scene. The Journal of Law, Medicine & Ethics 32:4, 641-657
CrossRef122
Andres T. Blei. (2004) Who owns the data?. Hepatology 40:6, 1237-1237
CrossRef123
Steinbrook, Robert, . (2004) Registration of Clinical Trials — Voluntary or Mandatory?. New England Journal of Medicine 351:18, 1820-1822
Full Text124
Anthony N. DeMaria. (2004) Publication bias and journals as policemen. Journal of the American College of Cardiology 44:8, 1707-1708
CrossRef
- Letters
